[
  {
    "ts": null,
    "headline": "Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up",
    "summary": "VCYT registers robust growth from its market-leading Decipher Prostate and Afirma tests in the first quarter of 2025.",
    "url": "https://finnhub.io/api/news?id=543939793ac79ebd4df6ddb5093d63a6cf9e85e597c376de7f4638e14684657a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746811740,
      "headline": "Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up",
      "id": 134362356,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "VCYT registers robust growth from its market-leading Decipher Prostate and Afirma tests in the first quarter of 2025.",
      "url": "https://finnhub.io/api/news?id=543939793ac79ebd4df6ddb5093d63a6cf9e85e597c376de7f4638e14684657a"
    }
  },
  {
    "ts": null,
    "headline": "TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down",
    "summary": "Increased organ utilization in liver and continued OCS adoption across both liver and heart boosted TransMedics' first-quarter 2025 performance.",
    "url": "https://finnhub.io/api/news?id=508934bc22b4b0179253d4c16401669b367cf51b926c7d760d7e019f8d337ccc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746806580,
      "headline": "TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down",
      "id": 134362357,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Increased organ utilization in liver and continued OCS adoption across both liver and heart boosted TransMedics' first-quarter 2025 performance.",
      "url": "https://finnhub.io/api/news?id=508934bc22b4b0179253d4c16401669b367cf51b926c7d760d7e019f8d337ccc"
    }
  },
  {
    "ts": null,
    "headline": "AMN Stock Gains Following Q1 Earnings & Revenue Beat, Margins Down",
    "summary": "AMN Healthcare's dismal results in all its segments led to a soft overall first-quarter 2025 performance.",
    "url": "https://finnhub.io/api/news?id=8edc8d263ef55b1c45ee20791237d9f51a90345f6e1fc69d6c3958875925525d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746806460,
      "headline": "AMN Stock Gains Following Q1 Earnings & Revenue Beat, Margins Down",
      "id": 134362358,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "AMN Healthcare's dismal results in all its segments led to a soft overall first-quarter 2025 performance.",
      "url": "https://finnhub.io/api/news?id=8edc8d263ef55b1c45ee20791237d9f51a90345f6e1fc69d6c3958875925525d"
    }
  },
  {
    "ts": null,
    "headline": "PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates",
    "summary": "Despite strong Service and other revenues, PACB reports soft first-quarter 2025 results partly due to lower Revio system shipments.",
    "url": "https://finnhub.io/api/news?id=dc81795586b90346cfa209947028bbd0856257ba6e0c964852c3488399f9a983",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746806400,
      "headline": "PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates",
      "id": 134362359,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Despite strong Service and other revenues, PACB reports soft first-quarter 2025 results partly due to lower Revio system shipments.",
      "url": "https://finnhub.io/api/news?id=dc81795586b90346cfa209947028bbd0856257ba6e0c964852c3488399f9a983"
    }
  },
  {
    "ts": null,
    "headline": "What Makes Boston Scientific Corporation (BSX) A Compelling Name Within The Large-Cap Medical Device Space?",
    "summary": "Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.54% (Institutional Shares) in the quarter compared to a 3.87% gain for the Russell 3000 Health Care Index (benchmark) and a 4.72% decline for the Russell […]",
    "url": "https://finnhub.io/api/news?id=e2e05153adb240f7a6383ecd6ff865fdb24a5e0d44681a94b87062ff17c13ac7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746800444,
      "headline": "What Makes Boston Scientific Corporation (BSX) A Compelling Name Within The Large-Cap Medical Device Space?",
      "id": 134362360,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.54% (Institutional Shares) in the quarter compared to a 3.87% gain for the Russell 3000 Health Care Index (benchmark) and a 4.72% decline for the Russell […]",
      "url": "https://finnhub.io/api/news?id=e2e05153adb240f7a6383ecd6ff865fdb24a5e0d44681a94b87062ff17c13ac7"
    }
  },
  {
    "ts": null,
    "headline": "Why Boston Scientific Corporation (BSX) Is Among the Best Medical Device Stocks to Buy Now",
    "summary": "We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other best medical device stocks to buy now. Trump’s Tariffs Are Dividing the Medical Community On April 16, CNBC reported that Trump’s tariffs […]",
    "url": "https://finnhub.io/api/news?id=8b5b5bc27e1f690ea4acc7aa7c9305e7b2ab6d3723fb8e851c24f15380a93742",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746791358,
      "headline": "Why Boston Scientific Corporation (BSX) Is Among the Best Medical Device Stocks to Buy Now",
      "id": 134362361,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other best medical device stocks to buy now. Trump’s Tariffs Are Dividing the Medical Community On April 16, CNBC reported that Trump’s tariffs […]",
      "url": "https://finnhub.io/api/news?id=8b5b5bc27e1f690ea4acc7aa7c9305e7b2ab6d3723fb8e851c24f15380a93742"
    }
  },
  {
    "ts": null,
    "headline": "Elutia Inc (ELUT) Q1 2025 Earnings Call Highlights: Strategic Growth and Challenges in Transition",
    "summary": "Elutia Inc (ELUT) reports significant growth in its bio envelope division and strategic partnerships, while addressing production constraints and cash flow management.",
    "url": "https://finnhub.io/api/news?id=36a2bf474a4455a880a1cdcfc36f441d6cf27090892a8010a8e0efec506c6ee7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746776899,
      "headline": "Elutia Inc (ELUT) Q1 2025 Earnings Call Highlights: Strategic Growth and Challenges in Transition",
      "id": 134335882,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Elutia Inc (ELUT) reports significant growth in its bio envelope division and strategic partnerships, while addressing production constraints and cash flow management.",
      "url": "https://finnhub.io/api/news?id=36a2bf474a4455a880a1cdcfc36f441d6cf27090892a8010a8e0efec506c6ee7"
    }
  }
]